Representation of a Fortune 500 pharmaceutical company in connection with the registration of billion dollar medium term note program. Also represented them in a number of takedowns from its shelf, including the sale of $450,000,000 of notes.
Please note that unsolicited emails and attached information sent to McGuireWoods or a firm attorney via this website do not create an attorney-client relationship. If you are not a McGuireWoods client, do not send us any confidential information. We may not respond to unsolicited emails and do not consider them or attached information confidential. That means we may disclose unsolicited emails and attachments to third parties, and your unsolicited communications will not prevent any lawyer in our firm from representing a party and using the unsolicited communications against you. By clicking "accept" you confirm that you have read and understand this notice.